Literature DB >> 34374548

Collective Asymmetric Total Syntheses of Marine Decahydroquinoline Alkaloid Lepadins A-E, H, and ent-I.

Foqing Ma1, Chenxi He1, Eryu Wang1, Rongbiao Tong1.   

Abstract

Lepadins are cis-fused decahydroquinoline (DHQ) marine alkaloids that have shown diverse biological activities and have attracted extensive synthetic interest. A new collective synthetic strategy is reported that features a green chemistry approach for constructing the common cis-fused DHQ core, which is achieved through green oxone-halide oxidation for both the aza-Achmatowicz rearrangement and the intramolecular [3 + 2] cycloaddition of nitrile oxide-alkene. Collective total syntheses of lepadins A-E and H are accomplished from the common DHQ core within 10 steps.

Entities:  

Year:  2021        PMID: 34374548     DOI: 10.1021/acs.orglett.1c02435

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  3 in total

1.  Identification of the Marine Alkaloid Lepadin A as Potential Inducer of Immunogenic Cell Death.

Authors:  Genoveffa Nuzzo; Carmela Gallo; Fabio Crocetta; Lucia Romano; Giusi Barra; Giuseppina Senese; Mario dell'Isola; Dalila Carbone; Valentina Tanduo; Federica Albiani; Guido Villani; Giuliana d'Ippolito; Emiliano Manzo; Angelo Fontana
Journal:  Biomolecules       Date:  2022-02-02

Review 2.  Marine Origin Ligands of Nicotinic Receptors: Low Molecular Compounds, Peptides and Proteins for Fundamental Research and Practical Applications.

Authors:  Igor Kasheverov; Denis Kudryavtsev; Irina Shelukhina; Georgy Nikolaev; Yuri Utkin; Victor Tsetlin
Journal:  Biomolecules       Date:  2022-01-23

3.  Insights into Cytotoxic Behavior of Lepadins and Structure Elucidation of the New Alkaloid Lepadin L from the Mediterranean Ascidian Clavelina lepadiformis.

Authors:  Marcello Casertano; Massimo Genovese; Paolo Paoli; Alice Santi; Anna Aiello; Marialuisa Menna; Concetta Imperatore
Journal:  Mar Drugs       Date:  2022-01-11       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.